基于T细胞的免疫疗法与瘤微环境之间的双向相互作用
Alfredo Pherez-Farah1, Gioia Boncompagni1, Aleksey Chudnovskiy2
1Laboratory of Synthetic Immunology, Department of Surgery, Oncology and Gastroenterology, University of Padua, Padua, Italy.
Cancer immunology research
|January 9, 2025
概括
基于T细胞的疗法会影响瘤微环境 (TME),这反过来又会影响疗法的有效性. 了解这种双向关系是改善癌症治疗结果和安全性的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症治疗 癌症治疗
背景情况:
- 基于T细胞的疗法,如瘤透性淋巴细胞疗法,T细胞受体工程T细胞和仿真抗原受体T细胞,是先进的癌症治疗方法.
- 这些疗法对癌细胞产生直接的细胞毒性作用.
- 新出现的证据强调它们对瘤微环境 (TME) 的显著影响.
研究的目的:
- 审查基于T细胞的疗法与TME之间的双向相互作用.
- 阐明这些疗法如何调节TME以及TME如何影响治疗活动.
- 为优化基于T细胞的癌症治疗的疗效和安全提供见解.
主要方法:
- 对临床和临床前数据的审查.
- 分析T细胞疗法与瘤微环境之间的相互作用.
- 综合当前关于作用机制,耐药性和毒性的知识.
主要成果:
- T细胞疗法通过改变细胞因子配置和招募免疫细胞来积极塑造TME.
- TME动态调节T细胞疗法的功能,促进或阻碍它们的抗瘤活性.
- 在T细胞疗法和TME之间存在双向通信.
结论:
- 了解T细胞疗法与TME之间的复杂相互作用至关重要.
- 这种知识对于破译治疗作用,耐药性和毒性的机制至关重要.
- 优化T细胞治疗的有效性和安全性依赖于对TME相互作用的彻底理解.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Tumor Immunotherapy
472
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
472
Cytotoxic T Cells-mediated Immune Response
841
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
841
T Cell Activation and Clonal Selection
651
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
651
Cancer Vaccines
337
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
337


